These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Hemodynamics analysis of intravascular stents with different design features]. Liang D; Yang D Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1241-4. PubMed ID: 17228717 [TBL] [Abstract][Full Text] [Related]
43. "Buddy in jail" or "buried wire" method: a critical review. Kaluski E; Tsai S; Milo-Cotter O; Klapholz M Catheter Cardiovasc Interv; 2010 Apr; 75(5):814; author reply 815. PubMed ID: 20146307 [No Abstract] [Full Text] [Related]
44. Pushing drug-eluting stents into uncharted territory: simpler than you think--more complex than you imagine. Rogers C; Edelman ER Circulation; 2006 May; 113(19):2262-5. PubMed ID: 16702484 [No Abstract] [Full Text] [Related]
45. Intracoronary radiation for in-stent restenosis in long lesions: too much, too little, too late? Gruberg L; Beyar R J Invasive Cardiol; 2003 Nov; 15(11):644-5. PubMed ID: 14608137 [No Abstract] [Full Text] [Related]
47. Aorto-ostial disease and aorto-ostial in-stent restenosis: poorly recognized but very complex lesion subsets. Satler LF Catheter Cardiovasc Interv; 2002 Jun; 56(2):220-1. PubMed ID: 12112917 [No Abstract] [Full Text] [Related]
48. Incidence, retrieval method, and outcomes of stent loss in percutaneous coronary intervention: a large single-center experience. Satler LF Catheter Cardiovasc Interv; 2005 Nov; 66(3):341-2. PubMed ID: 16142809 [No Abstract] [Full Text] [Related]
49. Bifurcation intervention: is it crush time yet? Williams DO; Abbott JD J Am Coll Cardiol; 2005 Aug; 46(4):621-4. PubMed ID: 16098425 [No Abstract] [Full Text] [Related]
50. Restenosis: another "dysfunction" of the endothelium. Lerman A Circulation; 2005 Jan; 111(1):8-10. PubMed ID: 15630036 [No Abstract] [Full Text] [Related]
51. Are drug-eluting stents cost-effective? It depends on whom you ask. Ryan J; Cohen DJ Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177 [No Abstract] [Full Text] [Related]
52. New drug-device combination helps keep arteries open. FDA Consum; 2003; 37(4):6. PubMed ID: 12971333 [No Abstract] [Full Text] [Related]
54. Hospital percutaneous coronary intervention volume and outcome: does it matter? Tcheng JE; Kindsvater S J Interv Cardiol; 2005 Feb; 18(1):17-9. PubMed ID: 15788049 [No Abstract] [Full Text] [Related]
55. Many breeds are better than a workhorse. Di Mario C Catheter Cardiovasc Interv; 2010 Jun; 75(7):1074-5. PubMed ID: 20517971 [No Abstract] [Full Text] [Related]
56. Late follow-up from RAVEL: transition from intention to observation. Laskey WK Circulation; 2005 Mar; 111(8):958-60. PubMed ID: 15738361 [No Abstract] [Full Text] [Related]
57. The importance of preclinical research in contemporary interventional cardiology. Joner M; Byrne RA EuroIntervention; 2010 May; 6(1):19-23. PubMed ID: 20542792 [No Abstract] [Full Text] [Related]
58. More modified crush techniques for coronary bifurcation lesions: which one is better? Chen S; Tan H; Lee M; ; ; Catheter Cardiovasc Interv; 2007 Feb; 69(3):468-9; author reply 469-70. PubMed ID: 17295288 [No Abstract] [Full Text] [Related]